Discovery and structure activity relationship of glyoxamide derivatives as anti-hepatitis B virus agents.

[1]  R. Schinazi,et al.  Erratum for Amblard et al., “Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses In Vitro and in Humanized Mice” , 2020, Antimicrobial Agents and Chemotherapy.

[2]  F. Pauwels,et al.  Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379 , 2020, Antimicrobial Agents and Chemotherapy.

[3]  R. Schinazi,et al.  Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses In Vitro and in Humanized Mice , 2019, Antimicrobial Agents and Chemotherapy.

[4]  M. Yuen,et al.  Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial. , 2019, The lancet. Gastroenterology & hepatology.

[5]  D. Liotta,et al.  Recent advances in the development of HBV capsid assembly modulators. , 2019, Current opinion in chemical biology.

[6]  R. Schinazi,et al.  Synthesis of sulfamoylbenzamide derivatives as HBV capsid assembly effector. , 2017, European journal of medicinal chemistry.

[7]  F. García-Alcalde,et al.  Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms , 2017, Scientific Reports.

[8]  R. Schinazi,et al.  Preclinical Characterization of GLS4, an Inhibitor of Hepatitis B Virus Core Particle Assembly , 2013, Antimicrobial Agents and Chemotherapy.

[9]  M. Otto,et al.  Antiviral Activities and Cellular Toxicities of Modified 2′,3′-Dideoxy-2′,3′-Didehydrocytidine Analogues , 2002, Antimicrobial Agents and Chemotherapy.

[10]  R. D. de Man,et al.  Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays , 2000, Journal of Clinical Microbiology.

[11]  M. Otto,et al.  Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication , 1997, Antimicrobial agents and chemotherapy.